Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

ENvue Medical (FEED) Total Current Liabilities (2017 - 2025)

Historic Total Current Liabilities for ENvue Medical (FEED) over the last 12 years, with Q3 2025 value amounting to $11.6 million.

  • ENvue Medical's Total Current Liabilities rose 36188.02% to $11.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was $11.6 million, marking a year-over-year increase of 36188.02%. This contributed to the annual value of $2.7 million for FY2024, which is 1092.09% up from last year.
  • Per ENvue Medical's latest filing, its Total Current Liabilities stood at $11.6 million for Q3 2025, which was up 36188.02% from $6.5 million recorded in Q2 2025.
  • ENvue Medical's Total Current Liabilities' 5-year high stood at $11.6 million during Q3 2025, with a 5-year trough of $266000.0 in Q3 2021.
  • Moreover, its 5-year median value for Total Current Liabilities was $2.4 million (2023), whereas its average is $3.0 million.
  • As far as peak fluctuations go, ENvue Medical's Total Current Liabilities crashed by 6872.0% in 2021, and later skyrocketed by 54473.68% in 2022.
  • Over the past 5 years, ENvue Medical's Total Current Liabilities (Quarter) stood at $1.9 million in 2021, then grew by 21.7% to $2.3 million in 2022, then grew by 5.96% to $2.5 million in 2023, then grew by 10.92% to $2.7 million in 2024, then skyrocketed by 327.77% to $11.6 million in 2025.
  • Its last three reported values are $11.6 million in Q3 2025, $6.5 million for Q2 2025, and $8.2 million during Q1 2025.